Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies
/in Chronic Leukemia, International Publications, Malignant LymphomaCancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses
/in Breast Cancer, International PublicationsMesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses
/in International Publications, Malignant Pleural MesotheliomaCirculating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation
/in Chronic Leukemia, International PublicationsPeripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma
/in International Publications, Malignant LymphomaImmunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice
/in Dendritic Cells, Hyperthermia, International PublicationsDendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses
/in International Publications, Malignant MelanomaCombined action of virus injection and local tumor irradiation on tumor growth in mice
/in International Publications, Newcastle Disease VirusLong-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
/in HIV/AIDS, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer